Look back in anger - what clinical studies tell us about preclinical work
about
Drug delivery of the future: Chasing the invisible gorillaDevelopmental neurotoxicity - challenges in the 21st century and in vitro opportunitiesBiological and medical applications of a brain-on-a-chipBiology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingCan animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal researchAbandon the mouse research ship? Not just yet!The human toxome projectNews Feature: Building benchtop human modelsStandard of reporting animal-based experimental research in Indian Journal of Pharmacology.Biofocussed chemoprospecting: An efficient approach for drug discovery.QSAR models of human data can enrich or replace LLNA testing for human skin sensitization.A versatile modular bioreactor platform for Tissue Engineering.Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity.In silico tools used for compound selection during target-based drug discovery and development.Analysis of Endothelial Adherence of Bartonella henselae and Acinetobacter baumannii Using a Dynamic Human Ex Vivo Infection Model.Systems Toxicology: The Future of Risk AssessmentA human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.The effect of shear flow on nanoparticle agglomeration and deposition in in vitro dynamic flow models.Cardiac stem cells: translation to human studies.Expanding the 3R principles: More rigour and transparency in research using animals.Quality assurance of metabolomics.A Human-Based Integrated Framework for Alzheimer's Disease Research.21st Century Cell Culture for 21st Century Toxicology.Adverse outcome pathways: opportunities, limitations and open questionsToxicity testing in the 21st century beyond environmental chemicals.The Lesioned Spinal Cord Is a "New" Spinal Cord: Evidence from Functional Changes after Spinal Injury in Lamprey.Policy reforms to update chemical safety testing.Animal Models in Translational Research: Rosetta Stone or Stumbling Block?[Experimental models of human skin aging].Genomic Instabilities, Cellular Senescence, and Aging: In Vitro, In Vivo and Aging-Like Human Syndromes.The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.Machine learning of toxicological big data enables read-across structure activity relationships (RASAR) outperforming animal test reproducibilityBig-data and machine learning to revamp computational toxicology and its use in risk assessment
P2860
Q24289432-EAD8614C-CDF7-4930-8055-DDC5B5829C65Q28388774-E804A858-FB98-4F78-B446-FDF9BECE7AECQ28973613-D8C0A968-7AF7-4483-9F31-B133EF8E5E1DQ30358385-7267745F-425C-40A9-AC43-01B631C0DBF7Q30983045-5C8AC622-3C8C-441A-81B8-566D0DBD019BQ34069683-AC5FCA9E-B501-488E-8D72-A99D5CD47F81Q34465807-CC959A41-EA55-4C19-886B-1EF12D896064Q35699108-120019E1-59AB-4848-8694-AA0AF284F2C7Q36210089-F3E4B404-FA59-4854-86D5-4C3D730865B6Q36264598-E7928B2A-2E13-4AD3-B7E5-5192C493939EQ36409883-59924EFA-4CCA-4632-A88B-9D065DD19D69Q37676845-5407CD56-7395-41CC-A2D8-A8D0303007CAQ37719183-D84DA900-239F-4936-91E3-92EE4B227E95Q38465124-C23C6C90-4C9D-45C9-A620-610B1E35D33EQ38680516-65816055-FA4D-4520-B626-811AF2EC304AQ38785209-B707C45C-376F-45D2-A712-8DE3CD9BDCF2Q38791196-D4562115-B31D-492C-8220-004DF1FFC82DQ38876652-4E007A8F-A242-4CA8-A824-0411125367ABQ39310120-5A540933-A3D2-43DA-90D2-8EE0E70FF800Q40119971-247456EA-3215-45EF-982B-53AFC862C268Q40356956-4961ED78-4B72-4C8C-B94F-265CD1AD014AQ40507217-44131D40-98AC-4580-AA09-59D40A849BE0Q41576330-A3BB6262-AC55-4E6A-ADB9-F22AC162FF33Q42307037-5CA1BB2C-F319-4644-BD66-AFC91EE78EF7Q44858463-139F2EA1-1E07-4DE8-8E3F-3E62B6CBDCE9Q44934033-E796ADCB-179F-4B32-A472-D0B91CB5D6F9Q45950813-590FEE31-860C-4614-8ADE-39BB0F50A75FQ50101264-D93565EE-FB53-4E86-99EE-6D0F2FA7D1B4Q52858064-2CA916CF-991E-4BF7-8A88-493042E40644Q55072429-BBF84B19-1BF5-4C10-85FC-7D084003B31DQ55312738-B2AB3940-428C-4413-9B54-4B48AF40B9FDQ55719723-CD6F9361-6D6D-4D78-AFC7-CC0CDAEB304FQ57497724-736D862F-2023-4FDB-8D2B-CFEBA61390E4
P2860
Look back in anger - what clinical studies tell us about preclinical work
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Look back in anger - what clinical studies tell us about preclinical work
@ast
Look back in anger - what clinical studies tell us about preclinical work
@en
Look back in anger - what clinical studies tell us about preclinical work
@nl
type
label
Look back in anger - what clinical studies tell us about preclinical work
@ast
Look back in anger - what clinical studies tell us about preclinical work
@en
Look back in anger - what clinical studies tell us about preclinical work
@nl
prefLabel
Look back in anger - what clinical studies tell us about preclinical work
@ast
Look back in anger - what clinical studies tell us about preclinical work
@en
Look back in anger - what clinical studies tell us about preclinical work
@nl
P2860
P356
P1476
Look back in anger - what clinical studies tell us about preclinical work
@en
P2093
Thomas Hartung
P2860
P304
P356
10.14573/ALTEX.2013.3.275
P407
P577
2013-01-01T00:00:00Z